Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingTax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exponent (EXPO) EBT (2016 - 2025)

Historic EBT for Exponent (EXPO) over the last 16 years, with Q4 2025 value amounting to $38.6 million.

  • Exponent's EBT rose 745.75% to $38.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $144.5 million, marking a year-over-year decrease of 110.18%. This contributed to the annual value of $147.4 million for FY2025, which is 844.32% up from last year.
  • According to the latest figures from Q4 2025, Exponent's EBT is $38.6 million, which was up 745.75% from $36.8 million recorded in Q3 2025.
  • Exponent's EBT's 5-year high stood at $40.4 million during Q1 2024, with a 5-year trough of $19.6 million in Q1 2021.
  • For the 5-year period, Exponent's EBT averaged around $33.7 million, with its median value being $34.3 million (2021).
  • Within the past 5 years, the most significant YoY rise in Exponent's EBT was 6188.94% (2021), while the steepest drop was 842.15% (2021).
  • Exponent's EBT (Quarter) stood at $28.7 million in 2021, then increased by 6.5% to $30.5 million in 2022, then fell by 1.41% to $30.1 million in 2023, then increased by 19.44% to $35.9 million in 2024, then grew by 7.46% to $38.6 million in 2025.
  • Its last three reported values are $38.6 million in Q4 2025, $36.8 million for Q3 2025, and $37.8 million during Q2 2025.